A bioluminescent immunoassay for methotrexate at the subpicomole level
- 1 September 1980
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 96 (1), 440-446
- https://doi.org/10.1016/0006-291x(80)91234-6
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Development and application of a radioimmunoassay for methotrexateBritish Journal of Cancer, 1977
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- Plasma levels of methotrexate in cancer patients as studied by an improved spectrophotofluorometric methodBiochemical Medicine, 1974
- Methotrexate toxicity: Correlation with duration of administration, plasma levels, dose and excretion patternEuropean Journal of Cancer (1965), 1972
- Blood Levels of Methotrexate and the Treatment of PsoriasisArchives of Dermatology, 1971
- Methotrexate Therapy of Wegener's GranulomatosisAnnals of Internal Medicine, 1971
- Parenteral Methotrexate in PsoriasisArchives of Dermatology, 1969
- Crystalline firefly luciferaseBiochimica et Biophysica Acta, 1956
- Analogs of Pteroylglutamic Acid. III. 4-Amino DerivativesJournal of the American Chemical Society, 1949
- Temporary Remissions in Acute Leukemia in Children Produced by Folic Acid Antagonist, 4-Aminopteroyl-Glutamic Acid (Aminopterin)New England Journal of Medicine, 1948